Literature DB >> 11368342

Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.

B E Maryanoff1, R J Santulli, D F McComsey, W J Hoekstra, K Hoey, C E Smith, M Addo, A L Darrow, P Andrade-Gordon.   

Abstract

Protease-activated receptor-2 (PAR-2) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-2 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-2 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-2. The most potent agonist peptides (EC50 = 2-4 microM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 microM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 microM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Ile and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368342     DOI: 10.1006/abbi.2000.2207

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Discovery of Novel Nonpeptidic PAR2 Ligands.

Authors:  Ilona Klösel; Maximilian F Schmidt; Jonas Kaindl; Harald Hübner; Dorothee Weikert; Peter Gmeiner
Journal:  ACS Med Chem Lett       Date:  2020-05-22       Impact factor: 4.345

Review 2.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 3.  Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.

Authors:  Nisha R Pawar; Marguerite S Buzza; Toni M Antalis
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

4.  Potent agonists of the protease activated receptor 2 (PAR2).

Authors:  Scott Boitano; Andrea N Flynn; Stephanie M Schulz; Justin Hoffman; Theodore J Price; Josef Vagner
Journal:  J Med Chem       Date:  2011-02-04       Impact factor: 7.446

5.  PAR2 Modulators Derived from GB88.

Authors:  Mei-Kwan Yau; Ligong Liu; Jacky Y Suen; Junxian Lim; Rink-Jan Lohman; Yuhong Jiang; Adam J Cotterell; Grant D Barry; Jeffrey Y W Mak; David A Vesey; Robert C Reid; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2016-10-10       Impact factor: 4.345

6.  High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2).

Authors:  Jordan C LeSarge; Pierre Thibeault; Mark Milne; Rithwik Ramachandran; Leonard G Luyt
Journal:  ACS Med Chem Lett       Date:  2019-06-06       Impact factor: 4.345

7.  Stimulation of protease-activated receptor-2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation.

Authors:  Benjamin A De Campo; Peter J Henry
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

8.  Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo.

Authors:  Morley D Hollenberg; Mahmoud Saifeddine; Sabrina Sandhu; Steeve Houle; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

9.  Essential role for proteinase-activated receptor-2 in arthritis.

Authors:  William R Ferrell; John C Lockhart; Elizabeth B Kelso; Lynette Dunning; Robin Plevin; Stephen E Meek; Andrew J H Smith; Gary D Hunter; John S McLean; Frances McGarry; Robert Ramage; Lu Jiang; Toru Kanke; Junichi Kawagoe
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

10.  Potent Small Agonists of Protease Activated Receptor 2.

Authors:  Mei-Kwan Yau; Jacky Y Suen; Weijun Xu; Junxian Lim; Ligong Liu; Mark N Adams; Yaowu He; John D Hooper; Robert C Reid; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2015-11-30       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.